Literature DB >> 2165264

Validity of imipramine platelet binding sites as a biological marker of endogenous depression. A World Health Organization Collaborative Study.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2165264     DOI： 10.1055/s-2007-1014492

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN： 0176-3679            Impact factor:   5.788


× No keyword cloud information.
  2 in total

1.  Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine.

Authors:  K M Lawrence; C L Katona; M T Abou-Saleh; M M Robertson; B L Nairac; D R Edwards; T Lock; R A Burns; D A Harrison; R W Horton
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

2.  Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine.

Authors:  K M Lawrence; J Falkowski; R R Jacobson; R W Horton
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.